Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.01 CAD -33.33%
Market Cap: 650k CAD
Have any thoughts about
Replicel Life Sciences Inc?
Write Note

Relative Value

RP doesn't have a meaningful market cap.

The Relative Value of one RP stock under the Base Case scenario is 0.04 CAD. Compared to the current market price of 0.01 CAD, Replicel Life Sciences Inc is Undervalued by 77%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RP Relative Value
Base Case
0.04 CAD
Undervaluation 77%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
19
Median 3Y
11.9
Median 5Y
16.8
Industry
4.1
vs History
vs Industry
Median 3Y
-9.9
Median 5Y
-4.1
Industry
32.7
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.2
Industry
22.1
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.2
Industry
33.6
vs History
vs Industry
Median 3Y
-0.6
Median 5Y
-1.3
Industry
2.6
vs History
85
vs Industry
17
Median 3Y
11.7
Median 5Y
16.6
Industry
3.9
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.6
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.9
Industry
18.5
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.9
Industry
23.7
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.1
Industry
21.4
vs History
vs Industry
Median 3Y
-2.3
Median 5Y
-3.1
Industry
28.8
vs History
vs Industry
Median 3Y
-23.5
Median 5Y
-20.9
Industry
2.4

Multiples Across Competitors

RP Competitors Multiples
Replicel Life Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Replicel Life Sciences Inc
XTSX:RP
614.3k CAD 1.7 -8.9 -0.5 -0.5
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.1 14.6 14.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Replicel Life Sciences Inc
XTSX:RP
Average EV/EBITDA: 177.5
Negative Multiple: -0.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 538.7
23%
67.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.4
19%
1.1
US
Danaher Corp
NYSE:DHR
26.9
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.3
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.4
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.3
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.4
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.6
52%
0.3

See Also

Discover More
Back to Top